This document is from our Archive and no action should be taken in reliance on it without specific legal advice. You can perform a search for more recent content. Inside Life Sciences Issue 4: March 2018 Post Brexit Update As the Brexit negotiations continue, the life sciences industry remains vocal. Post Access to information held by health regulators – transparency versus confidentiality On 5th February, the EU General Court gave its ruling on three separate cases (PTC Therapeutics v EMA, Pari Pharma v EMA and MSD Animal Health Innovation v EMA) Post CJEU rules on Roche/Novartis agreement restricting off label use of Avastin On 23 January 2018, the European Court of Justice (CJEU) handed down its judgment in Case C-179/16 relating to an on-going saga concerning Hoffman-La Roche Ltd (Roche) and Novartis AG (Novartis) and their attempts to restrict the off-label of Avastin. Previous Issues Prev Next Issue 13 Apr 2021 Issue 12 Nov 2020 Issue 11 Aug 2020 Issue 10 Jun 2020 Issue 9 Dec 2019 Issue 8 Jul 2019 Issue 7 Mar 2019 Issue 6 Nov 2018 Issue 5 Jul 2018 Issue 4 Mar 2018 Issue 3 Nov 2017 Share
Post Access to information held by health regulators – transparency versus confidentiality On 5th February, the EU General Court gave its ruling on three separate cases (PTC Therapeutics v EMA, Pari Pharma v EMA and MSD Animal Health Innovation v EMA)
Post CJEU rules on Roche/Novartis agreement restricting off label use of Avastin On 23 January 2018, the European Court of Justice (CJEU) handed down its judgment in Case C-179/16 relating to an on-going saga concerning Hoffman-La Roche Ltd (Roche) and Novartis AG (Novartis) and their attempts to restrict the off-label of Avastin.